Uninvolved liver dose prediction in stereotactic body radiation therapy for liver cancer based on the neural network method

基于神经网络方法的肝癌立体定向放射治疗中非受累肝脏剂量预测

阅读:1

Abstract

BACKGROUND: The quality of a radiotherapy plan often depends on the knowledge and expertise of the plan designers. AIM: To predict the uninvolved liver dose in stereotactic body radiotherapy (SBRT) for liver cancer using a neural network-based method. METHODS: A total of 114 SBRT plans for liver cancer were used to test the neural network method. Sub-organs of the uninvolved liver were automatically generated. Correlations between the volume of each sub-organ, uninvolved liver dose, and neural network prediction model were established using MATLAB. Of the cases, 70% were selected as the training set, 15% as the validation set, and 15% as the test set. The regression R-value and mean square error (MSE) were used to evaluate the model. RESULTS: The volume of the uninvolved liver was related to the volume of the corresponding sub-organs. For all sets of R-values of the prediction model, except for D(n0) which was 0.7513, all R-values of D(n10)-D(n100) and D(nmean) were > 0.8. The MSE of the prediction model was also low. CONCLUSION: We developed a neural network-based method to predict the uninvolved liver dose in SBRT for liver cancer. It is simple and easy to use and warrants further promotion and application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。